Pison builds a patented, non-invasive neural sensing platform that uses electroneurography (ENG) algorithms and a novel wrist sensor array to detect brain activity from three nerve bundles. Its AI (active and passive) extracts neurocognitive metrics to assess mental acuity and impairment from sleep loss, fatigue, anxiety, neurodegeneration, substances, and subconcussive injuries. The company targets applications across cognitive performance, fitness, safety, disease diagnostics and management, and gesture control. Pison has mobile apps and subscription services that it says will redefine cognitive performance and productivity across home, athletic, workplace, and mission-critical settings. Founded in 2016, Pison has received funding from MIT, the National Science Foundation, the ALS Association, and multiple SBIR awards from the U.S. Department of Defense. The company positions its technology as aligned with recent NDAA emphasis on neural biosensors for warfighter health and readiness. Founded in 2016 and led by CEO Dexter Ang, Pison Technology develops an insights platform that captures neuromuscular signals on the surface of the skin and combines them with machine learning and AI. Its core technology interprets intended hand and finger movements and transmits those signals to control digital devices, often before the physical motion is completed. The company positions its platform for innovations in medicine, sports performance, and general wellness. Pison has partnered in development with Google, Microsoft (Hololens), Mitsubishi Electric, Samsung, Boston Dynamics and others. It closed a $7M Series A and intends to use the funds to launch market-ready products with a series of ecosystem releases beginning in late 2021.

Total raised

$7M

Funding rounds

2

Latest round

Series A

Latest activity

Mar 2021